Cargando…
Kv1.3 channel blocker (ImKTx88) maintains blood–brain barrier in experimental autoimmune encephalomyelitis
BACKGROUND: Disruption of blood–brain barrier (BBB) and subsequent infiltration of auto-reactive T lymphocytes are major characteristics of multiple sclerosis (MS) and experimental autoimmune encephalomyelitis (EAE). Kv1.3 channel blockers are demonstrated potential therapeutic effects on MS patient...
Autores principales: | Huang, Jie, Han, Song, Sun, Qi, Zhao, Yipeng, Liu, Junchen, Yuan, Xiaolu, Mao, Wenqian, Peng, Biwen, Liu, Wanhong, Yin, Jun, He, Xiaohua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5463463/ https://www.ncbi.nlm.nih.gov/pubmed/28596825 http://dx.doi.org/10.1186/s13578-017-0158-2 |
Ejemplares similares
-
Cloning, expression and identification of KTX-Sp4, a selective Kv1.3 peptidic blocker from Scorpiops pococki
por: Zou, Yan, et al.
Publicado: (2017) -
Toxins Targeting the K(V)1.3 Channel: Potential Immunomodulators for Autoimmune Diseases
por: Zhao, Yipeng, et al.
Publicado: (2015) -
Inhibition of the NLRP3-inflammasome prevents cognitive deficits in experimental autoimmune encephalomyelitis mice via the alteration of astrocyte phenotype
por: Hou, Baohua, et al.
Publicado: (2020) -
The Scorpion Toxin Analogue BmKTX-D33H as a Potential Kv1.3 Channel-Selective Immunomodulator for Autoimmune Diseases
por: Ye, Fang, et al.
Publicado: (2016) -
Blockade of Kv1.3 Potassium Channel Inhibits Microglia-Mediated Neuroinflammation in Epilepsy
por: Zhang, Xinyi, et al.
Publicado: (2022)